Nexentis Technologies Inc.
NXTS Nasdaq· Pharmaceutical Preparations
Last close · Oct 23, 2026
$0.52
KIRA · Stoqly’s AI analyst, in plain words
- Nexentis Technologies Inc. had $0.0M of revenue in fiscal 2025, down 100.0% on the year before.
- Nexentis Technologies Inc. lost $4.0M in fiscal 2025.
- Free cash flow was −$3.8M in fiscal 2025, — of revenue.
- Nexentis Technologies Inc. has $3.3M more cash than debt.
Market cap
$0.4M
P/E
0.0x
Revenue
$0.0M
Net income
−$4.0M
Free cash flow
−$3.8M
Operating margin
—
Nexentis Technologies Inc. in 30 seconds · fiscal 2025
Are sales growing?
−100.0%
No. Sales fell 100.0% last year.
Does it make a profit?
−$4.0M
No. It lost money last year.
How healthy are the accounts?
3 / 7
Weak. It passes 3 of 7 health tests.
How is the share priced?
0.0x
One share costs 0.0 times its yearly profit per share.
What Nexentis Technologies Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 31, 2026
- Legal name
- Nexentis Technologies Inc.
- CIK
- 0001789192
Nexentis Technologies Inc. · NXTS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.4M | $0.4M | $0.3M | $0.2M | $0.0M |
| Revenue growth | 88.6% | −10.1% | −33.1% | −20.3% | −100.0% |
| Net interest income | — | −$0.0M | −$0.1M | −$0.1M | $0.0M |
| Gross margin | 69.0% | 59.8% | 79.0% | 21.4% | — |
| Operating margin | −1,073.6% | −1,477.1% | −2,877.0% | −1,563.3% | — |
| Net income | −$4.8M | −$5.7M | −$6.5M | −$5.2M | −$4.0M |
| Net margin | −1,100.3% | −1,456.8% | −2,476.1% | −2,472.9% | — |
| Diluted EPS | −$2.06 | $10.85 | −$5.43 | −$27.74 | −$8.61 |
| Cash | |||||
| Cash from operations | −$4.1M | −$5.1M | −$3.2M | −$3.4M | −$3.8M |
| Capital expenditure | $0.1M | $0.1M | — | — | $0.0M |
| Free cash flow | −$4.2M | −$5.1M | — | — | −$3.8M |
| FCF margin | −954.3% | −1,306.8% | — | — | — |
| Share count change | 54.2% | −77.4% | 127.0% | −84.4% | 588.1% |
| Debt and strength | |||||
| Cash and short-term investments | $6.8M | $5.7M | $4.4M | $2.2M | $4.1M |
| Debt incl. finance leases | $0.0M | — | — | — | $0.7M |
| Shareholders' equity | $6.5M | $5.8M | $6.5M | $4.7M | $16.0M |
| Current ratio | 7.8x | 8.8x | 7.0x | 3.9x | 4.2x |
| Returns and quality | |||||
| Return on capital | — | — | — | — | −26.4% |
| Return on equity | −159.4% | −93.1% | −105.8% | −92.5% | −38.6% |
| Return on tangible equity | −74.4% | −98.2% | −100.6% | −109.3% | −75.7% |
| Piotroski F-score | 4 | 4 | 2 | 3 | 3 |
| Altman Z'' | −0.3 | −3.7 | −7.3 | −16.0 | −2.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Nexentis Technologies Inc. · NXTS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.52 a share, the company is worth $0.4M: 0.0 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001789192). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.